HSP90AA1 and neuroblastoma: To determine the bio-functional cellular effects of the 17-AAG-mediated chemical inhibition of our target protein, HSP90, we first examined the proliferation rates of the MYCN-amplified IMR-32 compared to the non-MYCN-amplified SK-N-SH human NB cell lines over 96 h following the treatment.